Concepedia

M. Gabriela Kuba

MG

Statistics

Publications

15

Citations

1.6K

H-Index

13

Active since

2012

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Brigham and Women's Hospital

Vanderbilt University Medical Center

Yale University

University of California San Diego

M. Gabriela Kuba is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and pathology.

ORCID

Publications per year

2012–2024

15

Publications

15

TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer

Neil E. Bhola, Justin M. Balko, Teresa C. Dugger et al. · Journal of Clinical Investigation · 2013 · 593 citations · Full text

, , +17

Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue

Aileen I. Fernandez, Matthew Liu, Andrew M. Bellizzi et al. · JAMA Oncology · 2022 · 346 citations · Full text

, , +16

Trastuzumab-Resistant Cells Rely on a HER2-PI3K-FoxO-Survivin Axis and Are Sensitive to PI3K Inhibitors

Anindita Chakrabarty, Neil E. Bhola, Cammie R. Sutton et al. · Cancer Research · 2012 · 136 citations

, , +17

Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer

Emily Reisenbichler, Gang Han, Andrew M. Bellizzi et al. · Modern Pathology · 2020 · 130 citations · Full text

, , +6

Dual Blockade of HER2 in HER2-Overexpressing Tumor Cells Does Not Completely Eliminate HER3 Function

Joan T. Garrett, Cammie R. Sutton, M. Gabriela Kuba et al. · Clinical Cancer Research · 2012 · 99 citations · Full text

, , +15

1–5 of 15